LEBEL FRANCOIS (Chief Medical Officer) sold 3.1% of their position (10.82K shares) of SPECTRUM PHARMACEUTICALS INC on the open market
Open‑market sale worth $43.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/23/2021ACC: 0001209191-21-042775
Officer· Chief Medical Officer
Since Jun 2019
-10.82K
Net shares
Net seller
$43.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
10.82K disposed
Non-Derivative Transactions2
Common Stock, $0.001 par value
Direct
Shares
−5.82K
Price / share
$4.09
Trade value
$23.78K
% of position
1.7%
6/22/2021
350.87K→345.05K
Common Stock, $0.001 par value
Direct
Shares
−5K
Price / share
$4.00
Trade value
$20K
% of position
1.4%
6/23/2021
345.05K→340.05K
Total
Net shares
−10.82K
Net value
-$43.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value Direct | 6/22/2021 | S · Sale | −5.82K | $4.09 | $23.78K | 1.7% | 350.87K | 345.05K |
| Common Stock, $0.001 par value Direct | 6/23/2021 | S · Sale | −5K | $4.00 | $20K | 1.4% | 345.05K | 340.05K |
| Total | −10.82K | -$43.78K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, $0.001 par value
IndirectShares owned7.23K
Total
7.23K indirect7.23K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.001 par value | 7.23K | Indirect |
| Total | 7.23K | 7.23K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported